导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.47% | 688/1259 |
| 近一周 | -0.56% | 1268/1304 |
| 近一月 | -0.82% | 1017/1302 |
| 近一季 | -1.26% | 1134/1288 |
| 近半年 | 3.69% | 606/1283 |
| 近一年 | 5.29% | 573/1253 |
| 近两年 | 14.03% | 401/1200 |
| 近三年 | 12.49% | 399/1072 |
| 成立以来 | 61.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.18% 1006/1341 |
1.28% 500/1366 |
4.58% 473/1361 |
- - |
| 2024 | 8.25% 227/1373 |
-1.51% 1241/1403 |
0.97% 622/1402 |
5.93% 99/1374 |
2.76% 158/1373 |
| 2023 | -0.84% 686/1401 |
0.52% 1081/1367 |
-0.08% 596/1388 |
-2.15% 1077/1403 |
0.90% 89/1401 |
| 2022 | -3.58% 615/1336 |
-2.80% 482/1128 |
3.54% 229/1307 |
-2.17% 722/1325 |
-2.08% 1131/1336 |
| 2021 | 2.46% 521/1165 |
-1.09% 496/633 |
3.35% 172/921 |
-1.22% 801/1070 |
1.46% 607/1163 |
| 2020 | 19.02% 78/650 |
0.76% 149/336 |
5.11% 118/504 |
5.89% 140/587 |
6.12% 110/675 |
| 2019 | 13.33% 78/339 |
4.67% 2314/3053 |
1.18% 764/3201 |
3.72% 59/359 |
3.18% 144/372 |
| 2018 | 1.03% 102/297 |
- - |
-0.60% 833/2983 |
1.07% 381/2970 |
0.54% 343/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 国寿安保稳嘉混合C VS. () |